Skip to main content
TipRanks
Go Ultimate75% OFF

Sinco Pharmaceuticals Holdings Ltd. (6833) Stock Price & Analysis

0 Followers

6833 Stock Chart & Stats

HK$0.12HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$0.12HK$0.14HK$0.16Aug 18Aug 31Sep 16Sep 30Oct 12Oct 26Nov 9
Day’s Range
HKD 0.11 - HKD 0.12
52-Week Range
HKD 0.10 - HKD 0.23
Previous Close
HKD 0.12
Volume
N/A
Average Volume (3M)
61.93K
Market Cap
HKD 237.85M
Enterprise Value
HKD 164.08M
Total Cash (Recent Filing)
HKD 369.41M
Total Debt (Recent Filing)
HKD 116.76M
Price to Earnings (P/E)
6.4
Beta
-0.20
Next Earnings
Mar 31, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
1.43%

Bulls Say, Bears Say

Bulls Say

Improving Balance Sheet

The sustained reduction in leverage improves financial resilience and reduces the burden of debt service. Growing equity provides a stronger capital base, giving Sinco more flexibility to withstand operating pressure and support its distribution business over the next several quarters.

Recent Cash Flow Recovery

The return to solid positive operating and free cash flow indicates that the company recently converted activity into cash more effectively. If maintained, this recovery can support working-capital needs, preserve balance-sheet flexibility, and reduce reliance on external funding.

Positive Recent Net Income

Positive and relatively stable recent net income shows that Sinco continues to operate profitably despite weaker revenue and compressed margins. This provides an earnings base from which management can pursue operational improvements and protect the company’s ongoing market position.

Bears Say

Sharp Revenue Contraction

The reversal from earlier growth to an approximately 18% revenue decline signals pressure on business scale and demand conversion. Persistent contraction could reduce operating leverage, weaken bargaining power, and make it harder for Sinco to rebuild profitability over the medium term.

Thin And Compressed Margins

Very thin current margins leave limited room to absorb further operating pressure while still producing meaningful earnings. The decline from earlier profitability suggests weaker earnings power, and sustained compression could restrict reinvestment capacity and make results more sensitive to modest revenue changes.

Volatile Cash Generation

Although the latest period produced positive cash flow, the multi-year swings indicate that cash conversion has not been consistently reliable. This volatility raises execution and working-capital risk, making it harder to plan investment, distributions, and funding needs with confidence.

Sinco Pharmaceuticals Holdings Ltd. News

6833 FAQ

What was Sinco Pharmaceuticals Holdings Ltd.’s price range in the past 12 months?
Sinco Pharmaceuticals Holdings Ltd. lowest stock price was HK$0.10 and its highest was HK$0.23 in the past 12 months.
What is Sinco Pharmaceuticals Holdings Ltd.’s market cap?
Sinco Pharmaceuticals Holdings Ltd.’s market cap is HK$237.85M.
When is Sinco Pharmaceuticals Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sinco Pharmaceuticals Holdings Ltd.’s earnings last quarter?
Sinco Pharmaceuticals Holdings Ltd. released its earnings results on Aug 28, 2026. The company reported HK$0.011 earnings per share for the quarter.
Is Sinco Pharmaceuticals Holdings Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Sinco Pharmaceuticals Holdings Ltd. pay dividends?
Sinco Pharmaceuticals Holdings Ltd. pays an annual dividend of HK$0.002 which represents an annual dividend yield of 1.43%. See more information on Sinco Pharmaceuticals Holdings Ltd. dividends here
What is Sinco Pharmaceuticals Holdings Ltd.’s EPS estimate?
Sinco Pharmaceuticals Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sinco Pharmaceuticals Holdings Ltd. have?
Sinco Pharmaceuticals Holdings Ltd. has 2,032,890,600 shares outstanding.
What happened to Sinco Pharmaceuticals Holdings Ltd.’s price movement after its last earnings report?
Sinco Pharmaceuticals Holdings Ltd. reported an EPS of HK$0.011 in its last earnings report. Following the earnings report the stock price went down -0.599%.
Which hedge fund is a major shareholder of Sinco Pharmaceuticals Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:6833
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology